"Burkitt" is a creative documentary film about the life of Irish surgeon Denis Burkitt who discovered Burkitt's lymphoma - as told by first-time filmmaker Éanna Mac Cana - a survivor of this cancer.

Burkitt lymphoma is an aggressive cancer that starts in B cells, which are part of the immune system. It can lead to death, but intensive treatment can improve the likelihood of long-term survival. In ...

A study has found strong similarities between children with endemic Burkitt lymphoma — an aggressive cancer that attacks the body's defense system and children with silent malaria infection. Endemic ...

Research into the most prevalent tumors in developing countries significantly lags behind research into those cancers that are more common in Western countries, resulting in higher mortality rates.

A year after being diagnosed with Burkitt lymphoma, Abby Lee Miller is feeling optimistic about her future Abby Lee Miller is cancer free and could not feel more blessed. “The cancer is completely ...

One of the most common cancers in sub-Saharan Africa can be diagnosed more than seven times faster in those countries with use of liquid biopsies, according to new research. Compared with gold ...

Treatment schedule in an immunocompetent mouse model bearing a high burden of Burkitt’s lymphoma. While conventional CAR-T therapy alone resulted in no cures, adding five doses of a SUMOylation ...

Adult patients with Burkitt lymphoma can achieve equally sound survival outcomes with dose-adjusted chemotherapy vs high-intensity regimens, but can do so while avoiding the severe toxicities, US ...

Endemic Burkitt lymphoma is a highly aggressive B-cell non-Hodgkin lymphoma that predominates among children in regions where Plasmodium falciparum malaria is widespread. Long-term immunological ...

Burkitt's lymphoma is a rarely encountered, aggressive B-cell lymphoma that is highly curable in children and young adults. In middle-aged and older adults, however, administering curative therapy may ...

Evaluation of Sustained Minimal Residual Disease Negativity With Daratumumab-Combination Regimens in Relapsed and/or Refractory Multiple Myeloma: Analysis of POLLUX and CASTOR We derived the BL ...